The buffalo wings at Mugshots are so good, they should be illegal. These aren’t your run-of-the-mill, sauce-slathered chicken ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow morning. Here’s what to expect. Eli Lilly missed analysts’ revenue expectations by 6% last quarter ...

Eli Manning was only a four-time Pro Bowl quarterback in his 16-year NFL career, all with the New York Giants. He also didn't come close to being named All-Pro or winning MVP. But that likely won ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Seana Smith and Brad Smith examine several stocks on the move this morning: Pharmaceutical giant Eli Lilly (LLY) is cutting costs for GLP-1 weight-loss drug Zepbound. Keurig Dr Pepper (KDP ...

Eli Lilly expects 2024 revenue to be $45 billion, with Mounjaro and Zepbound sales contributing significantly. The company aims to increase Zepbound’s market share, competing with Novo Nordisk ...

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 earnings figures before tomorrow’s bell. Given recent price action, a buy ...

Eli Lilly (NYSE:LLY) is scheduled to announce Q4 earnings results on Thursday, February 6th, before market open. The consensus EPS Estimate is $5.11 (+105.2% Y/Y) and the consensus Revenue ...

Former Giants quarterback Eli Manning has previously expressed interest in NFL ownership, specifically with his former team. “It’s definitely something of interest,” Manning said in an ...

Seana Smith and Brad Smith examine several stocks on the move this morning: Pharmaceutical giant Eli Lilly (LLY) is cutting costs for GLP-1 weight-loss drug Zepbound. Keurig Dr Pepper (KDP) stock is ...

At least $241 million in taxpayer funds was spent on transgender surgeries and animal experiments, prompting a congressional lawmaker to question the rationale behind the expenditures. Rep.